drugset / Trial / NCT01678027

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

NCT01678027

Phase 3 Active not recruiting 1838 enrolled National Cancer Center, Korea
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study evaluate whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer in subjects with family history of gastric cancer.

Timeline

Start
2004-11
Primary completion
2018-12
Completion
2035-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Lansoprazole Other / unclassified 30 mg